4-tert-Pentylphenoxyalkyl derivatives - Histamine H3 receptor ligands and monoamine oxidase B inhibitors.

[1]  A. Salgado,et al.  Safinamide: a new hope for Parkinson's disease? , 2018, Drug discovery today.

[2]  Katarzyna Kieć-Kononowicz,et al.  The Histamine H3 Receptor Antagonist DL77 Ameliorates MK801-Induced Memory Deficits in Rats , 2018, Front. Neurosci..

[3]  Rona R. Ramsay,et al.  A perspective on multi-target drug discovery and design for complex diseases , 2018, Clinical and Translational Medicine.

[4]  Ondřej Soukup,et al.  Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases. , 2017, Angewandte Chemie.

[5]  H. Stark,et al.  Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H3R ligands. , 2017, Bioorganic & medicinal chemistry.

[6]  R. Ramsay.  Molecular aspects of monoamine oxidase B , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[7]  B. Sadek,et al.  Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats , 2016, Neuropharmacology.

[8]  H. Stark,et al.  Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents. , 2016, Bioorganic & medicinal chemistry.

[9]  K. Kieć‐Kononowicz,et al.  The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice , 2015, Physiology & Behavior.

[10]  C. Müller,et al.  Indazole- and indole-5-carboxamides: selective and reversible monoamine oxidase B inhibitors with subnanomolar potency. , 2014, Journal of medicinal chemistry.

[11]  A. Drabczyńska,et al.  1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. , 2013, Bioorganic & medicinal chemistry.

[12]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[13]  J. Schwartz,et al.  Ether derivatives of 3-piperidinopropan-1-ol as non-imidazole histamine H3 receptor antagonists. , 2006, Bioorganic & medicinal chemistry.

[14]  N. Panchuk-Voloshina,et al.  A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. , 1997, Analytical biochemistry.

[15]  H. Stark,et al.  Histamine H3R Antagonists: From Scaffold Hopping to Clinical Candidates , 2016 .